Cycloastragenol Skincare: Clinical Research on Aging Skin

Why Cycloastragenol Is Studied in Skincare

Cycloastragenol (CAG) is a naturally derived compound that has been studied in telomere- and telomerase-related biology. Its potential role in topical skincare has also been explored as part of multi-ingredient cosmetic formulations.

One published clinical study evaluated a finished topical product containing CAG together with growth factors, peptides and antioxidants. Because several active ingredients were combined in the tested formulation, the study does not establish that CAG alone produced the observed cosmetic changes.

What the Published Clinical Study Evaluated

A 12-week published clinical study evaluated a specific topical formulation containing cycloastragenol, growth factors, peptides and antioxidants.

The study enrolled 20 participants, with 18 completing the 12-week study. Assessments were performed at baseline and after 2, 4, 8 and 12 weeks.

The investigators reported statistically significant improvement after two weeks in the measured categories except erythema, with significant improvement across the evaluated categories at 12 weeks. Photographic improvement was reported as most notable in skin texture and lines around the cheeks and eye area.

Participants also reported improvement across multiple assessed categories, and no cases of sensitivity or irritation were reported during the study.

These findings relate to the specific multi-ingredient product that was tested. They should not be interpreted as evidence that cycloastragenol alone produced the observed results or that another formulation will necessarily produce the same effects.

What the Study Does — and Does Not — Show

The formulation combined several categories of ingredients that are independently studied in skin and cellular biology:

(1) Cycloastragenol

Cycloastragenol has been studied in telomerase- and telomere-related biological pathways. The topical study, however, did not establish that CAG alone lengthens telomeres or produces clinically meaningful telomerase activation in human skin.

(2) Growth Factors & Peptides

Growth factors and peptides are studied in cellular signaling, extracellular-matrix biology and skin appearance. Their presence in a combined formulation does not identify which ingredient was responsible for an observed clinical outcome.

(3) Antioxidants & Supporting Ingredients

Antioxidants and barrier-supporting ingredients are widely studied in oxidative-stress, hydration and skin-barrier research.

The biological pathways associated with these ingredients overlap with areas discussed in aging research, including the Hallmarks of Aging. The clinical study itself did not demonstrate that the tested cosmetic formulation modifies or reverses the Hallmarks of Aging.

Relevance for Skincare Professionals

The published study provides preliminary clinical evidence concerning the appearance of aging skin after use of the specific multi-ingredient formulation that was evaluated.

The study was relatively small and open-label, so its findings should be interpreted in the context of its design rather than generalized to every product containing cycloastragenol.

For skincare professionals, the research is useful as scientific context for formulation development, while the efficacy and tolerability of any finished product should be evaluated according to evidence for that specific formulation.

AgeReverse™ & Cycloastragenol

AgeReverse™ incorporates cycloastragenol into selected professional topical formulations, including:

⚬ Senolytic Solution
⚬ NewTone Solution
⚬ Bionic Serum

Research involving cycloastragenol or another multi-ingredient formulation provides scientific context for ingredient selection, but it should not be interpreted as clinical proof that AgeReverse finished products reproduce the outcomes reported in an independently studied formulation.

Continue Exploring the Clinical Research

Review the published clinical study for details of the formulation, study design and reported cosmetic outcomes. The study provides research context for cycloastragenol-containing skincare, while its findings remain specific to the multi-ingredient product that was evaluated.